Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-004372
Filing Date
2023-01-17
Accepted
2023-01-17 21:04:05
Documents
1
Period of Report
2023-01-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm231655-12_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm231655-12_4seq1.xml 4 9500
  Complete submission text file 0001104659-23-004372.txt   11075
Mailing Address C/O ADAPTIMMUNE THERAPEUTICS PLC 60 JUBILEE AVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address
Wood Gavin (Reporting) CIK: 0001577539 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37368 | Film No.: 23532732

Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Issuer) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)